qPCR Congress 2010
15th - 17th November
Monday 15th November 2010 to Wednesday 17th November 2010
London, UK, -
£650.00/person
Over two days, the event will attract over 120 senior-level decision makers working in qPCR from the UK, Europe and US. This conference explores effective strategies, technologies and applications of qPCR in accelerating drug discovery and development of clinical diagnostics
The event provides a forum for practitioners and prominent innovators to learn more about key solutions being provided to their industry, network with their peers, and address key industry concerns through a series of cutting edge conference presentations in a professional yet relaxed environment, during a 2 day conference programme
Day 1 - 15th November
qPCR Applications, Technology and Data Management
· Successful Gene Expression Analysis using real-time PCR
· Profiling technologies
· Other technologies: High resolution melt, Immuno PCR, Methylation sensitive PCR, SNP analysis, microRNA detection and Multiplex technologies
· Copy Number Variation
· Data Management / Bioinformatics: software applications, data mining, data visualization, biostatistics, multivariate statistics
Day 2 - 16th November
Stream 1: qPCR in Drug Discovery and Development
· Novel Uses of qPCR
· Single cell qPCR
· Assay optimisation and validation strategies
· qPCR in Biomarkers, Stem Cells, Oncology, HIV, Infectious & neurodegenrative diseases
· Development of clinical diagnostics and clinical Development
Day 3 - 17th November
Post Conference Workshop - Experimental Design and Quality Control in qPCR Experiments
|
 |
|
|
| Hear insights and views from our leading line up of industry experts: |
|
|
|
Yiu-Lian Fong, Director, Diagnostic Development, Novartis Molecular Diagnostics
|
|
|
|
Mikael Kubista, Head of gene Expression Laboratory, Institute of Biotechnology
|
|
|
|
Roman Artymyshyn, Target Discovery and Assessment, Lundbeck Research
|
|
|
|
Jan M. Ruijter, Image and Data Analyst, Dept. Anatomy and Embryology, Academic Medical Centre, Amsterdam
|
|
|
|
Pavel Neuzil, Korean Institute of Science and Technology, (KIST)
|
|
|
|
Jo Vandesompele, Centre for Medical Genetics Ghent (CMGG), Ghent University Hospital,
|
|
|
|
Frank McCaughan, MRC Career Development Fellow MRC Laboratory of Molecular Biology
|
|
|
|
Anders Stahlberg, Department of Chemistry and Biosciences, Chalmers University of Technology, Gothernberg University
|
|
|
|
Paola Rossatto, Lab. Researcher – Biology QC Department, MerckSerono
|
|
|
|
Philip Zimmermann, Group Leader ETH Zurich (Swiss Federal Institute of Technology),
|
|
|
|
Barbara D'Haene, Center for Genetics Ghent (CMGG), Ghent university Hospital
|
|
|
|
Victor Turcanu, Lecturer in Paediatric Allergy, King's College London and Honorary Lecturer in Allergy, Guy's and St. Thomas' NHS Foundation Trust, London
|
|
|
|
Nirmala Nanguneri, Director, Head of Biomarker Analysis and Informatics, Biomarker Development, Translational Sciences, Novartis Institutes for Biomedical Research
|
|
|
|
Ales Trichopad, Co-Founder and CTO Labonnet
|
|
|
|
Marco Tomasetti, Investigator, Department of Molecular Pathology anf Innovative Therapies, Polytechnic University of Marche, Ancona, Italy
|
|
|
|
Afif Abdel Nour Research Scientist, molecular Biotechnology, Institut Polytechnique LaSalla Beauvais
|
|
|
|
Fanny Schmidt, Post-Doctural Fellow, MerckSerono SA
|
|
|
|
|
|
|
|
|
Next Event
